Key result
In a rodent model of obesity-induced HFpEF, upregulation of natriuretic peptide receptor C (NPRC) contributed to disproportionate right ventricular remodeling by increasing cardiomyocyte hypertrophy.
Why the study?
HFpEF has no therapies that improve mortality, and an animal model of obesity-induced HFpEF with pulmonary hypertension was evaluated to gain insight into the pathogenesis of right ventricular failure.
Population
Two strains of mice (AKR and C3H) and H9C2 cells
Comparison
High fat (60% fat) vs control diet
Design
Preclinical animal and in vitro study
Follow-up
Up to 20 weeks
Authors
Loading...
Animal models of obesity-induced HFpEF may enable mechanistic RV studies; leaves open translation to human therapies.
NPRC contributes to right ventricular remodeling in obesity-induced pulmonary hypertension-HFpEF by increasing cardiomyocyte hypertrophy, representing a potential therapeutic target.
Agrawal et al. (2019) studied Obesity-induced heart failure with preserved ejection fraction (HFpEF) with pulmonary hypertension (n=96). High fat diet (60% fat) and NPRC overexpression vs. Nutrient matched control diet and empty vector was evaluated on Development of right ventricular dysfunction, pulmonary hypertension, and HFpEF, and NPRC expression. In a rodent model of obesity-induced HFpEF, upregulation of natriuretic peptide receptor C (NPRC) contributed to disproportionate right ventricular remodeling by increasing cardiomyocyte hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: